Excel Industries Reports Revenue Decline, Secures New Contract Manufacturing Deal
Excel Industries Limited faced a revenue decline in Q2FY26, with ₹270.00 crores compared to ₹309.50 crores in Q1FY26, due to prolonged monsoon and weak demand. H1FY26 revenue was ₹580.00 crores. Exports contributed 17.70% of Q2 revenue and 20.30% for H1. EBITDA margins were 11.10% for Q2 and 12.50% for H1, while PAT margins were 6.90% and 9.00% respectively. The company secured a 5-year contract manufacturing agreement worth ₹35.00-40.00 crores annually with a leading Indian specialty chemicals company. Excel Industries also expanded capacity for a biocide, operational from October 2025, and maintains market share in key products while focusing on portfolio diversification.

*this image is generated using AI for illustrative purposes only.
Excel Industries Limited has reported a decline in revenue for Q2FY26, citing prolonged monsoon and weak demand in key products. However, the company has secured a significant contract manufacturing agreement, potentially diversifying its revenue streams.
Financial Performance
For the quarter ended September 30, 2025 (Q2FY26), Excel Industries reported:
- Revenue of ₹270.00 crores, down from ₹309.50 crores in Q1FY26
- H1FY26 revenue stood at ₹580.00 crores
The company attributed the revenue decline to:
- Prolonged monsoon affecting agro demand
- Weak offtake in key products
Despite the challenges, Excel Industries maintained its export performance:
- Exports accounted for 17.70% of total revenue in Q2FY26
- For H1FY26, exports contributed 20.30% of total revenue
Profitability
The company's profitability was impacted by the lower demand:
- EBITDA margins were 11.10% for Q2FY26 and 12.50% for H1FY26
- PAT (Profit After Tax) margin stood at 6.90% for Q2FY26 and 9.00% for H1FY26
New Contract Manufacturing Agreement
In a strategic move to diversify its revenue sources, Excel Industries announced:
- A 5-year contract manufacturing agreement with a leading Indian specialty chemicals company
- The deal is valued at ₹35.00-40.00 crores per annum
- This agreement aims to reduce the company's dependence on the agrochemicals sector
Operational Highlights
Excel Industries has also made progress in its operational capabilities:
- Initiated a capacity expansion for one of its biocides
- The new capacity came on stream in October 2025
Market Position
Despite the challenging quarter, the company stated that it continues to:
- Maintain market share in key products
- Focus on diversification of its product portfolio
While the revenue decline presents short-term challenges, Excel Industries' new contract manufacturing agreement and capacity expansion efforts suggest a proactive approach to navigating market fluctuations and diversifying its business model. The company's ability to maintain export performance and market share in key products during a difficult quarter may indicate resilience in its core operations.
Historical Stock Returns for Excel Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.25% | -9.22% | -13.50% | -12.36% | -37.46% | +16.08% |


































